Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life

治疗失眠

基本信息

项目摘要

DESCRIPTION (provided by applicant): Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life This application addresses broad Challenge Area (04) Clinical Research and specific Challenge Topic, 04-NR- 103* Improving Quality of Life of Patients and Family Following a War-Related Traumatic Injury With an increase in active combat operations in recent years, the number of military personnel exposed to trauma is growing rapidly. One debilitating and far-reaching consequence of trauma for some individuals is the development of Post-Traumatic Stress Disorder (PTSD), with approximately 20% of veterans exposed to war- related trauma developing the disorder. Recent estimates suggest the prevalence within Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) veterans presenting for care at the VA is even higher. The short- and long-term negative consequences of PTSD for the individual, family, and society include reduced health- related quality of life, significant mental distress and comorbid psychiatric conditions, poor physical health, decreased family functioning, and loss of productivity. The healthcare consequences of these problems manifest in greater rates of self-reported poor health, increased numbers of primary care visits, and increased numbers of missed workdays. With increasing numbers of veterans returning from OEF/OIF, these personal and societal consequences are expected to grow in coming years. While effective treatments for the daytime symptoms of PTSD exist, they typically leave untreated the specific nighttime complaints of nightmares and insomnia. Nightmares and insomnia reported in the wake of traumatic events predict development of PTSD, and these disorders are independently associated with increased risk of health and psychiatric morbidities. Notably, chronic nightmares are associated with increased risk of substance abuse and suicide. Recognition of the negative impact of poor sleep and sleep disorders across patient populations has grown to the point where NIH convened a special conference in April 2009 entitled, "Sleepiness and Health Related Quality of Life" to highlight these issues. With respect to PTSD, studies have shown nightmares and insomnia often do not resolve without specifically targeted interventions, suggesting the negative consequences can build over more years. There are evidence-based treatments for both sleep disorders (Cognitive Behavioral Therapy for Insomnia, CBT-I; and Imagery Rehearsal Therapy, IRT), but they have not been thoroughly tested in individuals with military-related trauma, and no published studies report testing these interventions in recently deployed active duty personnel. Furthermore, it is unclear if treating sleep complaints will positively impact health-related quality of life and daytime symptoms more so than treatment focused only on daytime symptoms of PTSD. The overall objective of this study, then, is to examine if personalizing PTSD treatment by adding evidence-based sleep treatments in those patients with sleep complaints can better treat the full spectrum of PTSD symptoms (i.e., both daytime and nighttime) and improve health-related quality of life and overall clinical outcomes. This is a between-subjects randomized control trial. Participants with PTSD who also meet diagnostic criteria for both insomnia and recurring nightmares will be randomly assigned to one of two groups [Prolonged Exposure (PE) treatment only, or CBT-I/IRT + PE] equated for length of treatment. Assessments will be conducted at pretreatment, treatment weeks 5, 12, and 18, and post-treatment week 12. Assessments include objective and subjective measures of sleep disturbances, health-related quality of life, daytime PTSD symptoms, and other comorbid psychiatric symptoms. Patients will be recruited from the VA San Diego Healthcare System (where veterans are seen within a few month of returning from deployment) and the Naval Medical Center San Diego (where active duty personnel are seen even sooner post-deployment). To our knowledge: 1) this is the first study to examine the utility of CBT-I and IRT as an adjunct to other empirically validated PTSD treatments; 2) it will have a greater sample size than any currently published trial in combat- related PTSD; 3) it will be the first study to systematically examine these treatments in recently deployed active duty personnel; and 4) it will be the largest study of the sleep interventions to date to have health-related quality of life as a specifically targeted outcome. If our hypotheses are borne out, this study has the potential to provide valuable information in developing targeted treatment plans for combat-related PTSD, as well as to contribute to improvements in the overall well-being and quality of life in patients and, by extension, likely their families as well. Exposure to trauma, especially when it manifests as Post-Traumatic Stress Disorder, results in numerous negative consequences for patients, families, and society. Some of the most frequent, disturbing, and treatment resistant symptoms of PTSD are nightmares and insomnia. This study will examine whether treatments specifically targeted at those sleep disorders can improve clinical outcomes and increase health- related quality of life in individuals recently exposed to war-related trauma.
描述(由申请人提供):

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SEAN P.A. DRUMMOND其他文献

SEAN P.A. DRUMMOND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SEAN P.A. DRUMMOND', 18)}}的其他基金

IDENTIFYING THE SOURCE OF COGNITIVE DYSFUNCTION IN CHRONIC INSOMNIA
识别慢性失眠认知功能障碍的根源
  • 批准号:
    8166887
  • 财政年份:
    2009
  • 资助金额:
    $ 48.53万
  • 项目类别:
BEHAVIORAL AND NEURAL EFFECTS OF SLEEP DEPRIVATION ON DECISION MAKING
睡眠剥夺对决策的行为和神经影响
  • 批准号:
    8166843
  • 财政年份:
    2009
  • 资助金额:
    $ 48.53万
  • 项目类别:
SLEEP DEPRIVATION AND BRAIN FUNCTION IN OLDER ADULTS
老年人的睡眠剥夺和大脑功能
  • 批准号:
    8166802
  • 财政年份:
    2009
  • 资助金额:
    $ 48.53万
  • 项目类别:
Treating Insomnia & Nightmares After Trauma: Impact on Symptoms & Quality of Life
治疗失眠
  • 批准号:
    7935335
  • 财政年份:
    2009
  • 资助金额:
    $ 48.53万
  • 项目类别:
BEHAVIORAL AND NEURAL EFFECTS OF SLEEP DEPRIVATION ON DECISION MAKING
睡眠剥夺对决策的行为和神经影响
  • 批准号:
    7950992
  • 财政年份:
    2008
  • 资助金额:
    $ 48.53万
  • 项目类别:
SLEEP DEPRIVATION AND BRAIN FUNCTION IN OLDER ADULTS
老年人的睡眠剥夺和大脑功能
  • 批准号:
    7950936
  • 财政年份:
    2008
  • 资助金额:
    $ 48.53万
  • 项目类别:
EFFECTS OF MODAFINIL, NAPPING & CAFFEINE ON PERCEPTUAL DETERIORATION & LEARNING
莫达非尼的影响,小睡
  • 批准号:
    7724917
  • 财政年份:
    2007
  • 资助金额:
    $ 48.53万
  • 项目类别:
SLEEP DEPRIVATION AND BRAIN FUNCTION IN OLDER ADULTS
老年人的睡眠剥夺和大脑功能
  • 批准号:
    7724913
  • 财政年份:
    2007
  • 资助金额:
    $ 48.53万
  • 项目类别:
EFFECTS OF TOTAL SLEEP DEPRIVATION AND RECOVERY SLEEP ON BRAIN FUNCTION
完全睡眠剥夺和恢复睡眠对大脑功能的影响
  • 批准号:
    7606522
  • 财政年份:
    2006
  • 资助金额:
    $ 48.53万
  • 项目类别:
EFFECTS OF TOTAL SLEEP DEPRIVATION AND RECOVERY SLEEP ON BRAIN FUNCTION
完全睡眠剥夺和恢复睡眠对大脑功能的影响
  • 批准号:
    7374169
  • 财政年份:
    2006
  • 资助金额:
    $ 48.53万
  • 项目类别:

相似海外基金

Drought and Climate Resilience of Smallholders in Afghanistan: Needs and Preferences Analysis
阿富汗小农的干旱和气候抵御能力:需求和偏好分析
  • 批准号:
    24K16366
  • 财政年份:
    2024
  • 资助金额:
    $ 48.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
'Diaspora States' in Somalia and Afghanistan: New Perspectives on Post-War Politics, Dual Citizenship and International Statebuilding
索马里和阿富汗的“侨民国家”:战后政治、双重国籍和国际国家建设的新视角
  • 批准号:
    EP/X022048/1
  • 财政年份:
    2023
  • 资助金额:
    $ 48.53万
  • 项目类别:
    Fellowship
Improving learning outcomes in Afghanistan and Pakistan in the midst of COVID-19 through Community based system dynamics and project-based learning
通过基于社区的系统动态和基于项目的学习,在 COVID-19 期间改善阿富汗和巴基斯坦的学习成果
  • 批准号:
    ES/X014088/1
  • 财政年份:
    2022
  • 资助金额:
    $ 48.53万
  • 项目类别:
    Research Grant
On Politics and Justice: British Military Justice following War Crimes Allegations in Iraq and Afghanistan, 2001-present
论政治与司法:2001 年至今,伊拉克和阿富汗战争罪指控后的英国军事司法
  • 批准号:
    2745904
  • 财政年份:
    2022
  • 资助金额:
    $ 48.53万
  • 项目类别:
    Studentship
U.S and Afghanistan - why the nation-building project failed?
美国和阿富汗——国家建设项目为何失败?
  • 批准号:
    22K01385
  • 财政年份:
    2022
  • 资助金额:
    $ 48.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Market Economy and Conflict; Disjuncture between the Politics and Economics of Statebuilding in Afghanistan during 2001-2021
市场经济与冲突;
  • 批准号:
    ES/X006832/1
  • 财政年份:
    2022
  • 资助金额:
    $ 48.53万
  • 项目类别:
    Fellowship
Analysis of the structure of conflict between ethnicities in the transformation of national integration policy in Afghanistan
阿富汗民族融合政策转型中的族群冲突结构分析
  • 批准号:
    19K20529
  • 财政年份:
    2019
  • 资助金额:
    $ 48.53万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era Veterans
神经类固醇干预伊拉克/阿富汗时期退伍军人的创伤后应激障碍
  • 批准号:
    10417141
  • 财政年份:
    2019
  • 资助金额:
    $ 48.53万
  • 项目类别:
Neurosteroid Intervention for PTSD in Iraq/Afghanistan-era Veterans
神经类固醇干预伊拉克/阿富汗时期退伍军人的创伤后应激障碍
  • 批准号:
    10589071
  • 财政年份:
    2019
  • 资助金额:
    $ 48.53万
  • 项目类别:
A pilot assessment of miltefosine's efficacy and tolerability for treating cutaneous Leishmania tropica in Afghanistan
在阿富汗对米替福辛治疗皮肤热带利什曼原虫的疗效和耐受性进行初步评估
  • 批准号:
    MR/R018391/1
  • 财政年份:
    2018
  • 资助金额:
    $ 48.53万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了